Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet
— Read on www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext
Categories